Discounted Cash Flow
Akso Health Group ADR
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2017 | $22.9m | $8.6m | $8.2m | 37.4% | $0.20 |
| 2018 | $107.3m (368.0%) | $65.5m (664.0%) | $87.7m (971.1%) | 61.1% (63.3%) | $1.46 (630.0%) |
| 2019 | $61.3m (-42.8%) | $5.5m (-91.6%) | $-1.7m (-102.0%) | 9.0% (-85.2%) | $0.11 (-92.5%) |
| 2020 | $11.4m (-81.4%) | $-71.2m (-1386.9%) | $-55.9m (-3127.2%) | -622.6% (-7002.1%) | $-1.46 (-1427.3%) |
| 2021 | $1.8m (-84.7%) | $-34.8m (51.1%) | $10.1m (118.0%) | -1984.5% (-218.7%) | $-0.71 (51.4%) |
| 2022 | $6.3m (259.6%) | $-16.9m (51.6%) | $-8.6m (-185.8%) | -267.0% (86.5%) | $-0.28 (60.6%) |
| 2023 | $13.2m (108.9%) | $-1.4m (91.9%) | $-3.3m (62.3%) | -10.3% (96.1%) | $-0.02 (92.9%) |
| 2024 | $2.4m (-81.7%) | $-9.5m (-595.5%) | $1.4m (141.5%) | -391.8% (-3697.4%) | $-0.07 (-250.0%) |
| 2025 | $14.8m (512.1%) | $-135.0m (-1327.0%) | $1.0m (-24.3%) | -913.4% (-133.1%) | $-0.16 (-128.6%) |
| 2026 | $13.8m (-6.4%) | $-18.7m (86.2%) | $-18.7m (-1925.7%) | -135.0% (85.2%) | $-0.03 (81.2%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.